In addition, serum irisin concentrations in type 2 diabetic women were significantly lower than in the normal controls, while the serum irisin concentrations in diabetic patients with atherosclerosis were lower than in diabetic patients without atherosclerosis [54]. This evidence concerns the gene FNDC5 and atherosclerosis.